Business Context and Reporting Period
Company: Boston Scientific Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: September 7, 2026
Event: Update on a material cybersecurity incident originally identified on August 25, 2026, which caused a global disruption to operations, manufacturing, and order fulfillment.
Key Financial Metrics
The filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity for the current period. The document focuses on the operational impact of the cybersecurity incident rather than reporting finalized financial statements.
Material Changes and Operational Impact
- Operational Status: The incident caused unauthorized activity and network outages affecting operating systems and business applications. As of the filing date, there is no evidence of ongoing unauthorized access.
- Recovery Progress: Substantial restoration of the distribution network has occurred, with major centers processing orders at or above normal levels. Sterilization facilities are operational, and manufacturing has resumed across most global facilities.
- Financial Impact: The Company has determined the incident will likely have a material impact on results of operations for the third quarter and full year 2026.
- Guidance Revision: The Company believes it is unlikely to meet previously provided net sales growth and adjusted EPS guidance ranges for Q3 and full-year 2026 (issued July 29, 2026).
Outlook, Risks, and Management Commentary
- Future Outlook: The timeline for full operational recovery remains uncertain. The Company anticipates recovering some portion of impacted revenue as operations ramp up and backlogs are reduced, but the full financial impact is not yet known.
- Long-Term View: Management does not expect the incident to have a material impact on the Company's long-term financial condition.
- Next Update: An update on operational and financial outlook for the remainder of fiscal year 2026 is scheduled for the Q3 2026 conference call on October 28, 2026.
- Risks: Key risks include potential litigation, reputational damage, regulatory scrutiny, unauthorized release of confidential data, and diversion of management attention. The filing includes a standard cautionary statement regarding forward-looking statements.
Investor Verification Checklist
- Verify the extent of data exfiltration or unauthorized access during the August 25, 2026 incident.
- Monitor the October 28, 2026 conference call for revised Q3 and full-year 2026 financial guidance.
- Assess the timeline for full restoration of all affected systems and the potential for recurring disruptions.
- Review potential litigation risks and regulatory actions stemming from the cybersecurity breach.
- Track the reduction of order backlogs and the rate of revenue recovery in subsequent reporting periods.